Historical record - last NADAC publication: 1/19/2022

Product Information

MORPHINE SULFATE ER 30 MG CAP is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $3.3842 per EA under NDC 00115127801. Its NADAC has been published 267 times since Feb 8, 2017.

MORPHINE SULFATE ER 30 MG CAP

MORPHINE SULFATE
$3.3842per EA
DEA Schedule CII

Strength

30 mg/1

NDC

00115127801

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Last Updated

1/19/2022

Active Ingredients

MORPHINE SULFATE

Approval Type

Generic (ANDA)

FDA Application

ANDA200411

On Market Since

4/12/2016

Pharmacological Classes

Full Opioid Agonists
Opioid Agonist

Price Statistics

The NADAC for MORPHINE SULFATE ER 30 MG CAP has been published 267 times since Feb 8, 2017, and over the history we have for it it has risen 13.5%. The table below summarizes its recorded NADAC range and movement.

Current price$3.3842 per EA
All-time high$3.6410 (Jan 10, 2018)
All-time low$1.8067 (Oct 23, 2019)
Median price$2.8177
Average price$2.8712
Largest weekly change+51.3% (Nov 18, 2020)
Weeks tracked267
Tracking sinceFeb 8, 2017

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

+20.1%

All

+13.5%

Generic Alternatives

The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 88% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of MORPHINE SULFATE ER 30 MG CAP?

The current National Average Drug Acquisition Cost (NADAC) for MORPHINE SULFATE ER 30 MG CAP, manufactured by Amneal Pharmaceuticals of New York LLC, is $3.3842 per EA (NDC 00115127801), effective Mar 16, 2022.

How has the price of MORPHINE SULFATE ER 30 MG CAP changed over time?

Over the history we have for it, the NADAC for MORPHINE SULFATE ER 30 MG CAP has risen 13.5%. It has been tracked across 267 weekly CMS publications since Feb 8, 2017.

What are the highest and lowest recorded NADAC prices for MORPHINE SULFATE ER 30 MG CAP?

Since Feb 8, 2017, the NADAC for MORPHINE SULFATE ER 30 MG CAP has ranged from a low of $1.8067 (Oct 23, 2019) to a high of $3.6410 (Jan 10, 2018), with a median of $2.8177 per EA.

Are there cheaper alternatives to MORPHINE SULFATE ER 30 MG CAP?

Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, MORPHINE SULFATE IR 30 MG TAB, is $0.4148 per EA — about 88% below MORPHINE SULFATE ER 30 MG CAP.

Who manufactures MORPHINE SULFATE ER 30 MG CAP?

MORPHINE SULFATE ER 30 MG CAP (NDC 00115127801) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.